1530 related articles for article (PubMed ID: 33769683)
1. SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done.
Luo R; Delaunay-Moisan A; Timmis K; Danchin A
Environ Microbiol; 2021 May; 23(5):2339-2363. PubMed ID: 33769683
[TBL] [Abstract][Full Text] [Related]
2. Patterns of within-host genetic diversity in SARS-CoV-2.
Tonkin-Hill G; Martincorena I; Amato R; Lawson ARJ; Gerstung M; Johnston I; Jackson DK; Park N; Lensing SV; Quail MA; Gonçalves S; Ariani C; Spencer Chapman M; Hamilton WL; Meredith LW; Hall G; Jahun AS; Chaudhry Y; Hosmillo M; Pinckert ML; Georgana I; Yakovleva A; Caller LG; Caddy SL; Feltwell T; Khokhar FA; Houldcroft CJ; Curran MD; Parmar S; ; Alderton A; Nelson R; Harrison EM; Sillitoe J; Bentley SD; Barrett JC; Torok ME; Goodfellow IG; Langford C; Kwiatkowski D;
Elife; 2021 Aug; 10():. PubMed ID: 34387545
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.
Chen AT; Altschuler K; Zhan SH; Chan YA; Deverman BE
Elife; 2021 Feb; 10():. PubMed ID: 33620031
[TBL] [Abstract][Full Text] [Related]
4. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
5. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
[TBL] [Abstract][Full Text] [Related]
6. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
[TBL] [Abstract][Full Text] [Related]
7. Taxonium, a web-based tool for exploring large phylogenetic trees.
Sanderson T
Elife; 2022 Nov; 11():. PubMed ID: 36377483
[TBL] [Abstract][Full Text] [Related]
8. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.
González-Candelas F; Shaw MA; Phan T; Kulkarni-Kale U; Paraskevis D; Luciani F; Kimura H; Sironi M
Infect Genet Evol; 2021 Aug; 92():104869. PubMed ID: 33915216
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
Gong W; Parkkila S; Wu X; Aspatwar A
Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
[TBL] [Abstract][Full Text] [Related]
12. Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients.
Wang Y; Wang D; Zhang L; Sun W; Zhang Z; Chen W; Zhu A; Huang Y; Xiao F; Yao J; Gan M; Li F; Luo L; Huang X; Zhang Y; Wong SS; Cheng X; Ji J; Ou Z; Xiao M; Li M; Li J; Ren P; Deng Z; Zhong H; Xu X; Song T; Mok CKP; Peiris M; Zhong N; Zhao J; Li Y; Li J; Zhao J
Genome Med; 2021 Feb; 13(1):30. PubMed ID: 33618765
[TBL] [Abstract][Full Text] [Related]
13. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
Elife; 2022 Aug; 11():. PubMed ID: 36004719
[TBL] [Abstract][Full Text] [Related]
14. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
[TBL] [Abstract][Full Text] [Related]
15. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
Elife; 2022 May; 11():. PubMed ID: 35587653
[TBL] [Abstract][Full Text] [Related]
16. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
[TBL] [Abstract][Full Text] [Related]
17. Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction.
Mollentze N; Keen D; Munkhbayar U; Biek R; Streicker DG
Elife; 2022 Nov; 11():. PubMed ID: 36416537
[TBL] [Abstract][Full Text] [Related]
18. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
19. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
[TBL] [Abstract][Full Text] [Related]
20. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
Mondal T; Shivange G; Habieb A; Tushir-Singh J
Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
